The Lancet: First nationally representative estimate of COVID-19 seroprevalence in the U.S. suggests few in the population developed antibodies in the first wave

(The Lancet) The first cross-sectional, nation-wide analysis of more than 28,000 patients on dialysis in the U.S. found that fewer than 10% of U.S. adults had COVID-19 antibodies as of July 2020 and fewer than 10% were diagnosed.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news